NPI: 1366492977 · WASHINGTON, DC 20016 · General Acute Care Hospital · NPI assigned 05/12/2006
Authorized official DAVIS, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | DAVIS, RICHARD (PRESIDENT) |
| NPI Enumeration Date | 05/12/2006 |
Other providers sharing the same authorized official: DAVIS, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,435 | $1.18M |
| 2019 | 46,393 | $1.69M |
| 2020 | 46,056 | $1.69M |
| 2021 | 63,995 | $2.59M |
| 2022 | 55,958 | $3.61M |
| 2023 | 53,419 | $4.16M |
| 2024 | 44,246 | $4.18M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,243 | 15,195 | $4.22M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,615 | 11,914 | $3.18M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,155 | 7,818 | $1.94M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,514 | 4,109 | $1.37M |
| 70450 | Computed tomography, head or brain; without contrast material | 3,743 | 3,404 | $1.19M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,015 | 837 | $762K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,479 | 1,410 | $631K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,255 | 1,129 | $530K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3,137 | 1,783 | $502K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,850 | 2,359 | $471K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3,033 | 2,703 | $455K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,885 | 1,627 | $384K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,071 | 1,718 | $378K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,493 | 3,021 | $349K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,070 | 967 | $330K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,039 | 960 | $240K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 466 | 406 | $221K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 864 | 794 | $208K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,812 | 2,462 | $118K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 549 | 470 | $115K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 265 | 238 | $114K |
| 80053 | Comprehensive metabolic panel | 26,572 | 20,737 | $111K |
| G0378 | Hospital observation service, per hour | 3,121 | 1,294 | $97K |
| 93971 | 851 | 784 | $95K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,053 | 427 | $92K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 709 | 341 | $69K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 376 | 315 | $62K |
| 76830 | Ultrasound, transvaginal | 838 | 777 | $57K |
| 96367 | 363 | 241 | $43K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 743 | 655 | $39K |
| 80320 | 1,513 | 1,262 | $37K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,121 | 964 | $36K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 468 | 440 | $33K |
| 87631 | 902 | 843 | $33K | |
| 97161 | 272 | 247 | $32K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 225 | 182 | $32K |
| 70544 | 49 | 41 | $30K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 28,346 | 21,701 | $29K |
| 71046 | Radiologic examination, chest; 2 views | 2,022 | 1,862 | $27K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 518 | 170 | $22K |
| 72131 | 225 | 213 | $21K | |
| 71250 | 242 | 209 | $19K | |
| 97804 | 39 | 39 | $18K | |
| 97116 | 229 | 126 | $18K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 12 | 12 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 33 | 26 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,491 | 2,819 | $15K |
| 93970 | 63 | 57 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,442 | 2,577 | $14K |
| 71045 | Radiologic examination, chest; single view | 6,642 | 5,758 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 855 | 781 | $13K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,127 | 962 | $13K |
| 96415 | 20 | 12 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,187 | 8,800 | $12K |
| 0002A | 422 | 348 | $11K | |
| 0001A | 378 | 346 | $11K | |
| 83880 | 1,371 | 1,149 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,082 | 5,501 | $9K |
| 93975 | 54 | 52 | $8K | |
| 97803 | 41 | 41 | $8K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,231 | 7,114 | $8K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 418 | 394 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 749 | 694 | $7K |
| 87040 | 1,449 | 686 | $7K | |
| 36415 | Collection of venous blood by venipuncture | 4,176 | 3,071 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,419 | 1,150 | $6K |
| 97113 | 29 | 12 | $6K | |
| 84484 | 6,950 | 5,217 | $6K | |
| 86850 | 2,412 | 1,749 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 27 | 26 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 666 | 579 | $4K |
| 85379 | 893 | 805 | $4K | |
| 81001 | 7,474 | 6,589 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,124 | 5,434 | $3K |
| 87186 | 767 | 644 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 4,997 | 2,398 | $3K |
| 82962 | 5,418 | 2,567 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 12 | 12 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,032 | 2,712 | $3K |
| 85027 | 1,529 | 1,054 | $3K | |
| 73030 | 329 | 295 | $3K | |
| 73630 | 301 | 273 | $3K | |
| 73564 | 594 | 545 | $3K | |
| 86900 | 2,494 | 1,817 | $3K | |
| 83605 | 2,521 | 1,892 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 125 | 117 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 47 | 40 | $2K |
| 84703 | 7,007 | 6,220 | $2K | |
| 97162 | 13 | 12 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 977 | 879 | $2K |
| 76801 | 41 | 36 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,834 | 5,835 | $2K |
| 36591 | 19 | 15 | $2K | |
| 83735 | 2,891 | 2,139 | $2K | |
| 86920 | 13 | 12 | $2K | |
| 86901 | 2,518 | 1,840 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 870 | 642 | $1K |
| 85610 | 2,958 | 2,508 | $1K | |
| 97165 | 14 | 12 | $1K | |
| 81003 | 2,581 | 2,305 | $1K | |
| 84439 | 170 | 135 | $956.30 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 97 | 84 | $936.02 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 741 | 671 | $894.36 |
| 90715 | 21 | 19 | $799.34 | |
| 83690 | 5,893 | 5,111 | $647.82 | |
| 0012A | 13 | 12 | $576.81 | |
| 84702 | 525 | 457 | $534.85 | |
| J3490 | Unclassified drugs | 3,287 | 1,902 | $527.65 |
| 70486 | 13 | 13 | $494.68 | |
| 73610 | 116 | 106 | $449.47 | |
| 87077 | 901 | 747 | $432.56 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,731 | 2,230 | $397.63 |
| 83036 | Hemoglobin; glycosylated (A1C) | 176 | 142 | $394.15 |
| 0031A | 12 | 12 | $324.54 | |
| 97535 | Self-care/home management training, each 15 minutes | 17 | 12 | $286.58 |
| J7070 | Infusion, d5w, 1000 cc | 1,344 | 552 | $261.98 |
| 94799 | 30 | 12 | $233.34 | |
| 85730 | 1,304 | 1,149 | $219.59 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,009 | 1,013 | $158.01 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,369 | 1,145 | $141.25 |
| 96376 | 1,507 | 1,271 | $125.54 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,063 | 4,294 | $124.80 |
| 84466 | 45 | 39 | $122.12 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,774 | 2,499 | $107.08 |
| 83540 | 45 | 39 | $100.35 | |
| 86140 | 104 | 80 | $73.60 | |
| J2704 | Injection, propofol, 10 mg | 3,487 | 1,668 | $69.99 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,515 | 1,757 | $54.91 |
| 84100 | 144 | 97 | $54.88 | |
| 82728 | 15 | 12 | $54.50 | |
| 73130 | 45 | 40 | $40.43 | |
| J7050 | Infusion, normal saline solution, 250 cc | 751 | 410 | $38.48 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,736 | 3,233 | $34.30 |
| 87800 | 12 | 12 | $31.92 | |
| 85652 | 95 | 85 | $29.74 | |
| 87070 | 51 | 47 | $28.28 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 917 | 747 | $22.87 |
| A9270 | Non-covered item or service | 15,107 | 4,327 | $20.96 |
| 80061 | Lipid panel | 30 | 26 | $15.21 |
| 82077 | 403 | 331 | $14.72 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,413 | 1,051 | $14.31 |
| 80076 | 192 | 166 | $13.23 | |
| 82550 | 95 | 75 | $11.80 | |
| 81015 | 63 | 60 | $8.98 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 395 | 183 | $8.37 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,648 | 1,181 | $6.12 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 752 | 535 | $6.06 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 578 | 514 | $2.18 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 433 | 347 | $1.32 |
| J2060 | Injection, lorazepam, 2 mg | 506 | 391 | $1.20 |
| J0690 | Injection, cefazolin sodium, 500 mg | 198 | 153 | $0.48 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 158 | 105 | $0.24 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 16 | 14 | $0.24 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 31 | 24 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 36 | 25 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 21 | 13 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 21 | 12 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 12 | 12 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 87 | 63 | $0.00 |
| 87430 | 33 | 31 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 43 | 26 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 13 | 12 | $0.00 |
| 0637 | 889 | 302 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 75 | 70 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 102 | 90 | $0.00 |
| G1012 | Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program | 123 | 89 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 12 | 12 | $0.00 |
| 82948 | 16 | 13 | $0.00 | |
| 96417 | 133 | 94 | $0.00 | |
| 81025 | 13 | 12 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 220 | 63 | $0.00 |
| 94664 | 30 | 25 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 41 | 33 | $0.00 |